Qianfang Technology (002373): R & D expands and expands Yushi’s overseas momentum is good The company issued an interim report: the operating income for 19H1 was 35. 900 million, an annual increase of 25%; net
Haida Group (002311)： Performance growth is deterministic and optimistic about long-term development
Haida Group (002311): Performance growth is deterministic and optimistic about long-term development Company status Haida Group has performed well since the third quarterly report. The third quarterly report has the highest increase of about 12%.
Self-tested different pain methods predict disease severity Pain is a response to disease, and Chinese medicine believes that the specific sensations of pain are different and the causes are different, suggesting that the possible diseases